Zengbin Wang

401 total citations
22 papers, 272 citations indexed

About

Zengbin Wang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Zengbin Wang has authored 22 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Zengbin Wang's work include Immune Cell Function and Interaction (7 papers), IL-33, ST2, and ILC Pathways (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Zengbin Wang is often cited by papers focused on Immune Cell Function and Interaction (7 papers), IL-33, ST2, and ILC Pathways (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Zengbin Wang collaborates with scholars based in China, United States and Nepal. Zengbin Wang's co-authors include Nanhong Tang, Banglun Pan, Xiaoxia Zhang, Xiaoqian Wang, Lirong Peng, Yuxin Yao, Shuling Shen, Tao Zhang, Yizhong Chen and Xiaoxia Zhang and has published in prestigious journals such as Analytical Chemistry, Advanced Science and Toxicology and Applied Pharmacology.

In The Last Decade

Zengbin Wang

17 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zengbin Wang China 10 157 82 82 62 26 22 272
Yoko Naito Japan 9 154 1.0× 25 0.3× 46 0.6× 73 1.2× 30 1.2× 18 255
Sara Centuori United States 11 173 1.1× 124 1.5× 44 0.5× 151 2.4× 35 1.3× 21 385
Untack Cho South Korea 9 206 1.3× 57 0.7× 134 1.6× 55 0.9× 32 1.2× 13 361
Tianyang Liu China 11 204 1.3× 47 0.6× 46 0.6× 58 0.9× 23 0.9× 20 342
Hanwen Xu United States 10 193 1.2× 29 0.4× 75 0.9× 70 1.1× 25 1.0× 18 292
Lin Yu China 10 134 0.9× 49 0.6× 48 0.6× 77 1.2× 24 0.9× 22 292
Sarah Röthlisberger Colombia 7 235 1.5× 35 0.4× 81 1.0× 31 0.5× 16 0.6× 14 346
Xu Xiao China 11 390 2.5× 33 0.4× 156 1.9× 49 0.8× 17 0.7× 24 456
Banglun Pan China 10 153 1.0× 91 1.1× 102 1.2× 73 1.2× 37 1.4× 24 270

Countries citing papers authored by Zengbin Wang

Since Specialization
Citations

This map shows the geographic impact of Zengbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengbin Wang more than expected).

Fields of papers citing papers by Zengbin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zengbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengbin Wang. The network helps show where Zengbin Wang may publish in the future.

Co-authorship network of co-authors of Zengbin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zengbin Wang. A scholar is included among the top collaborators of Zengbin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zengbin Wang. Zengbin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Biqiu, et al.. (2025). Doxorubicin promotes NK cell dysfunction and induces acute liver injury through kynurenine-AhR axis. International Immunopharmacology. 153. 114489–114489.
2.
3.
Wang, Zengbin, et al.. (2024). Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells. Frontiers in Pharmacology. 15. 1394241–1394241. 4 indexed citations
4.
Liu, Zhiyu, Qing Zhong, Zengbin Wang, et al.. (2024). Appraisal of surgical outcomes and oncological efficiency of intraoperative adverse events in robotic radical gastrectomy for gastric cancer. Surgical Endoscopy. 38(4). 2027–2040. 1 indexed citations
5.
Wang, Yang, et al.. (2024). Change Patterns of Major Functional Components in the Loquat Summer Shoot Leaf during Annual Growth. Journal of the American Society for Horticultural Science. 149(6). 320–326.
6.
Pan, Banglun, et al.. (2023). 2,5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis. Journal for ImmunoTherapy of Cancer. 11(6). e006817–e006817. 29 indexed citations
7.
Wang, Zengbin, Banglun Pan, Yuxin Yao, et al.. (2023). XPO1 intensifies sorafenib resistance by stabilizing acetylation of NPM1 and enhancing epithelial-mesenchymal transition in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 160. 114402–114402. 16 indexed citations
8.
Wang, Zengbin & Nanhong Tang. (2023). Unpacking the complexity of nuclear IL-33 (nIL-33): a crucial regulator of transcription and signal transduction. Journal of Cell Communication and Signaling. 17(4). 1131–1143. 5 indexed citations
9.
Pan, Banglun, Zengbin Wang, Yuxin Yao, et al.. (2023). TGF-β-p-STAT1-LAIR2 axis has a “self-rescue” role for exhausted CD8+ T cells in hepatocellular carcinoma. Cellular Oncology. 46(6). 1625–1644. 9 indexed citations
10.
Pan, Banglun, Zengbin Wang, Xiaoxia Zhang, et al.. (2023). Targeted inhibition of RBPJ transcription complex alleviates the exhaustion of CD8+ T cells in hepatocellular carcinoma. Communications Biology. 6(1). 123–123. 10 indexed citations
11.
Wang, Zengbin, et al.. (2023). IL-33/ST2 antagonizes STING signal transduction via autophagy in response to acetaminophen-mediated toxicological immunity. Cell Communication and Signaling. 21(1). 80–80. 15 indexed citations
12.
Wang, Zengbin, Banglun Pan, Xiaoxia Zhang, et al.. (2023). SUMOylated IL-33 in the nucleus stabilizes the transcription factor IRF1 in hepatocellular carcinoma cells to promote immune escape. Science Signaling. 16(776). eabq3362–eabq3362. 19 indexed citations
13.
Wang, Zengbin, Banglun Pan, Lili Su, et al.. (2023). SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma. Cellular Oncology. 47(2). 513–532. 13 indexed citations
14.
Pan, Banglun, Zengbin Wang, Xiaoxia Zhang, et al.. (2023). Single-cell atlas reveals characteristic changes in intrahepatic HBV-specific leukocytes. Microbiology Spectrum. 12(1). e0286023–e0286023. 1 indexed citations
15.
Peng, Lirong, Banglun Pan, Xiaoxia Zhang, et al.. (2022). Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression. Cell Biology and Toxicology. 38(6). 1159–1173. 82 indexed citations
16.
Wang, Zengbin, Xiaoli He, Shi Chen, et al.. (2022). GJA1 reverses arsenic-induced EMT via modulating MAPK/ERK signaling pathway. Toxicology and Applied Pharmacology. 450. 116138–116138. 7 indexed citations
17.
Li, Dapei, et al.. (2022). Identifying and expression analysis of WD40 transcription factors in walnut. The Plant Genome. 15(3). e20229–e20229. 9 indexed citations
18.
He, Yuehui, et al.. (2021). Culture-Free Identification and Metabolic Profiling of Microalgal Single Cells via Ensemble Learning of Ramanomes. Analytical Chemistry. 93(25). 8872–8880. 25 indexed citations
19.
20.
Wang, Zengbin, Xiaotong Li, Xiaoli He, et al.. (2020). Autophagy mediates bronchial cell malignant transformation induced by chronic arsenic exposure via MEK/ERK1/2 pathway. Toxicology Letters. 332. 155–163. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoko Naito Breakdown of academic impact, for papers by Sara Centuori Breakdown of academic impact, for papers by Untack Cho Breakdown of academic impact, for papers by Tianyang Liu Breakdown of academic impact, for papers by Hanwen Xu Breakdown of academic impact, for papers by Lin Yu Breakdown of academic impact, for papers by Sarah Röthlisberger Breakdown of academic impact, for papers by Xu Xiao Breakdown of academic impact, for papers by Banglun Pan
Rankless by CCL
2026